R. Keefe
Psychiatry and Mental health · American Journal of Psychiatry · 2001–2023
A researcher in the Science corpus: 11 papers; trusts 3 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Psychiatry and Mental health — 38 citations into it; #969 of 1,338 by trust here, #164 by citations
- Cognitive Neuroscience — 30 citations into it
Whom R. Keefe trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts R. Keefe overall
Papers from R. Keefe's perspective
Ordered by how strongly the researchers R. Keefe trusts endorse each paper. Same corpus, a different order for every researcher.
- Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. (American Journal of Psychiatry)
- Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. (Schizophrenia Research)
- Identification of separable cognitive factors in schizophrenia. (Schizophrenia Research)
- The positive and negative syndrome scale (PANSS) for schizophrenia.
- A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. (International Journal of Neuropsychopharmacology)
- Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. (American Journal of Psychiatry)
- The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. (American Journal of Psychiatry)
- Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. (American Journal of Psychiatry)
- Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. (Biological Psychiatry)
- The RAND/UCLA Appropriateness Method User's Manual
Their papers
- Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment (2023) — 599 citations
- Schizophrenia is a cognitive illness: time for a change in focus. (2013) — 811 citations
- Persistent cannabis users show neuropsychological decline from childhood to midlife (2012) — 1,450 citations
- The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. (2008) — 2,265 citations
- The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. (2008) — 731 citations
- Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. (2007) — 1,086 citations
- Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. (2006) — 963 citations
- Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. (2005) — 5,425 citations
- Antipsychotic drug effects on brain morphology in first-episode psychosis. (2005) — 765 citations
- Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. (2004) — 935 citations
- Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. (2001) — 637 citations